Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Mirati Therapeutics (MRTX)

Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mirati Therapeutics 3545 CRAY COURT SAN DIEGO CA 92121 USA

www.mirati.com P: 858-332-3410

Description:

Mirati Therapeutics, Inc. is a clinical-stage biotech developing kinase inhibitors and KRAS inhibitors.

Key Statistics

Overview:

Market Capitalization, $K 4,117,688
Enterprise Value, $K 3,882,428
Shares Outstanding, K 70,148
Annual Sales, $ 12,440 K
Annual Net Income, $ -740,870 K
Last Quarter Sales, $ 16,400 K
Last Quarter Net Income, $ -161,900 K
EBIT, $ -764,260 K
EBITDA, $ -765,530 K
60-Month Beta 0.77
% of Insider Shareholders 3.26%
Float, K 67,861
% Float 96.74%
Short Volume Ratio 0.30

Growth:

1-Year Return 28.56%
3-Year Return -71.41%
5-Year Return -11.86%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -374.10%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.49 on 11/06/23
Next Earnings Date 02/27/24
Earnings Per Share ttm -12.22
EPS Growth vs. Prev Qtr 18.09%
EPS Growth vs. Prev Year 19.42%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MRTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -82.15%
Return-on-Assets % -67.82%
Profit Margin % -5,955.55%
Debt/Equity 0.00
Price/Sales 91.82
Price/Cash Flow N/A
Price/Book 3.63
Book Value/Share 16.15
Interest Coverage -2.09
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar